Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence and clinical relevance of serum anti-p53 antibodies in patients with cholangiocarcinoma.

Asian Pacific journal of allergy and immunology - 1 Sept 2000

Tangkijvanich P, Kasemsupatana K, Janchai A, Kullavanijaya P, Theamboonlers A, Poovorawan Y

Abstract excerpt

Cholangiocarcinoma (CCA) constitutes carcinoma of the bile duct found at a high prevalence in northeastern Thailand. In the present study, we examined the sera of altogether 82 Thai CCA patients for the presence of anti-p53 antibodies in order to investigate a role of the tumor suppressor gene, p53 in the carcinogenesis. Our results revealed anti-p53 antibodies in 7.3% of the cases tested, which conforms to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Fetoproteins
Share to Antibodies, Antinuclear

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antibodies, Neoplasm

Share to Bile Duct Neoplasms

Share to Bile Ducts, Intrahepatic

Share to Cholangiocarcinoma

Share to Enzyme-Linked Immunosorbent Assay

Share to Serum Albumin

Source

Identifiers

PMID: 11270475

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence and clinical relevance of serum anti-p53 antibodies in patients with cholangiocarcinoma.PMID 11270475Read ↗

Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and ThailandSemantic proximity Read ↗

Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma.Semantic proximity Read ↗

Cancer genes and cholangiocarcinoma.Semantic proximity Read ↗

Ratio disruption of the Δ133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinomaSemantic proximity Read ↗

Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.Semantic proximity Read ↗

Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma.Semantic proximity Read ↗

[Clinical importance of serum anti-p53 antibodies as tumor markers].Semantic proximity Read ↗

Viral hepatitis B, C infection and genotype distribution among cholangiocarcinoma patients in northeast Thailand.Semantic proximity Read ↗

Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients.Semantic proximity Read ↗

Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India.Semantic proximity Read ↗

K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.Semantic proximity Read ↗

p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.